Metronidazole 250 MG

DRUG3 trials

Sponsors

Juan Blanco Carrión, National Cheng-Kung University Hospital

Conditions

Bismuth Quadruple TherapyDysbiosisHelicobacter Pylori InfectionPeri-ImplantitisProbioticsSex

Phase 4

Metronidazole as an Adjunct of Non- Surgical Treatment of Peri-implantitis

CompletedNCT03564301

Juan Blanco CarriónPeri-Implantitis

Start: 2018-03-03End: 2020-12-22Updated: 2021-04-28

The Efficacy of 10-day and 14-day Bismuth-based Quadruple Therapy in First-line H. Pylori Eradication

Enrolling by invitationNCT04527055

National Cheng-Kung University HospitalDysbiosis, Helicobacter Pylori Infection, Probiotics

Start: 2020-05-06End: 2028-07-31Target: 312Updated: 2024-06-24

Optimal Duration of Bismuth Quadruple Therapy for Helicobacter Pylori Eradication in Females As Compared with Males

Enrolling by invitationNCT06509139

National Cheng-Kung University HospitalBismuth Quadruple Therapy, Helicobacter Pylori Infection, Sex

Start: 2024-07-09End: 2032-07-31Target: 661Updated: 2024-11-07

Related Papers

The systemic impact of non‐surgical treatment of peri‐implantitis with or without adjunctive systemic metronidazole: Secondary analysis of a randomized clinical trial

Clinical Oral Implants Research2024-08-021 citations

10-Day versus 14-day bismuth quadruple therapy for first-line eradication of <i>Helicobacter pylori</i> infection: a randomised, open-label, non-inferiority trial.

2024-03-1120 citations

Evolution of the Correa's cascade steps: A long-term endoscopic surveillance among non-ulcer dyspepsia and gastric ulcer after H. pylori eradication

Journal of the Formosan Medical Association2022-11-3017 citations

Adjunctive benefits of systemic metronidazole on non‐surgical treatment of peri‐implantitis. A randomized placebo‐controlled clinical trial

Journal Of Clinical Periodontology2021-10-2863 citations